Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
J Surg Res. 2010 Nov;164(1):e1-11. doi: 10.1016/j.jss.2010.07.041. Epub 2010 Aug 17.
Lower levels of myocardial Akt activity in males are associated with a higher incidence of heart failure and worsened cardiac function after ischemia/reperfusion (I/R). While Akt activation by estrogen provides cardioprotection in females, no information exists regarding the effect of testosterone on the myocardial Akt pathway following I/R. We hypothesized that following I/R: (1) endogenous testosterone will decrease myocardial Akt activation in male hearts; (2) endogenous testosterone will mediate downstream signals of Akt, including Bad, Bcl-2, and FOXO3a; (3) administration of exogenous testosterone will recapitulate negative effects on the Akt pathway in castrated male hearts.
Rat hearts from age-matched adult males, females, castrated males, males with androgen receptor blocker-flutamide, castrated males with chronic 5α-dihydrotestosterone (DHT) implantation, or acute testosterone infusion (ATI) (n = 9/group) were subjected to I/R (Langendorff). Castration or flutamide treatment significantly up-regulated myocardial Akt activation, increased downstream apoptosis-regulatory molecules p-Bad, Bcl-2, p-FOXO3a, but reduced Fas-L, consistent with decreased myocardial injury in male hearts following I/R. ATI administration, but not chronic DHT, reversed these effects on Akt signaling associated with further exacerbated cardiac dysfunction in castrated males. Notably, lower levels of MnSOD were observed in male hearts, and castration or flutamide treatment restored myocardial MnSOD expression to the levels of females in male hearts after I/R.
Our study represents the initial evidence of testosterone-induced down-regulation of the Akt pathway in male hearts following I/R, thereby mediating cardiac injury through decreased p-Bad, reduced ratio of Bcl-2/Bax in the cytoplasm, and increased FOXO3a in the nucleus.
男性心肌 Akt 活性降低与心力衰竭发生率增加以及缺血/再灌注(I/R)后心脏功能恶化有关。虽然雌激素激活 Akt 可提供女性心脏保护,但关于 I/R 后睾酮对心肌 Akt 途径的影响尚无信息。我们假设在 I/R 后:(1)内源性睾酮会降低雄性心脏中的心肌 Akt 激活;(2)内源性睾酮将介导 Akt 的下游信号,包括 Bad、Bcl-2 和 FOXO3a;(3)外源性睾酮的给药将在去势雄性心脏中再现对 Akt 途径的负面影响。
来自年龄匹配的成年雄性、雌性、去势雄性、雄激素受体阻滞剂氟他胺雄性、慢性 5α-二氢睾酮(DHT)植入去势雄性或急性睾酮输注(ATI)(n = 9/组)的大鼠心脏接受 I/R(Langendorff)。去势或氟他胺治疗显著上调心肌 Akt 激活,增加下游凋亡调节分子 p-Bad、Bcl-2、p-FOXO3a,但减少 Fas-L,与雄性心脏 I/R 后心肌损伤减少一致。ATI 给药而非慢性 DHT 逆转了这些与 Akt 信号相关的影响,导致去势雄性心脏的心脏功能进一步恶化。值得注意的是,雄性心脏中的 MnSOD 水平较低,去势或氟他胺治疗可恢复雄性心脏中的 MnSOD 表达,使其达到 I/R 后雌性心脏的水平。
我们的研究代表了 I/R 后雄性心脏中睾酮诱导的 Akt 途径下调的初步证据,从而通过降低细胞质中的 p-Bad、减少 Bcl-2/Bax 的比值以及增加核中的 FOXO3a 来介导心脏损伤。